Hoffmann, M.; Banz, Y.; Halter, J.; Schoumans, J.; Tchinda, J.; Bacher, U.; Pabst, T.
True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report. Curr. Oncol. 2024, 31, 2067-2075.
https://doi.org/10.3390/curroncol31040153
AMA Style
Hoffmann M, Banz Y, Halter J, Schoumans J, Tchinda J, Bacher U, Pabst T.
True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report. Current Oncology. 2024; 31(4):2067-2075.
https://doi.org/10.3390/curroncol31040153
Chicago/Turabian Style
Hoffmann, Michèle, Yara Banz, Jörg Halter, Jacqueline Schoumans, Joëlle Tchinda, Ulrike Bacher, and Thomas Pabst.
2024. "True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report" Current Oncology 31, no. 4: 2067-2075.
https://doi.org/10.3390/curroncol31040153
APA Style
Hoffmann, M., Banz, Y., Halter, J., Schoumans, J., Tchinda, J., Bacher, U., & Pabst, T.
(2024). True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report. Current Oncology, 31(4), 2067-2075.
https://doi.org/10.3390/curroncol31040153
